中国临床新医学
中國臨床新醫學
중국림상신의학
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
2014年
5期
431-433
,共3页
李妮%卢桂南%孙泽勇%苏航就%陈燕%韦小娟
李妮%盧桂南%孫澤勇%囌航就%陳燕%韋小娟
리니%로계남%손택용%소항취%진연%위소연
Graves病%肾脏%游离甲状腺激素%促甲状腺受体抗体%尿微量蛋白%131 I治疗
Graves病%腎髒%遊離甲狀腺激素%促甲狀腺受體抗體%尿微量蛋白%131 I治療
Graves병%신장%유리갑상선격소%촉갑상선수체항체%뇨미량단백%131 I치료
Graves disease ( GD)%Kidney%Free thyroid hormone%Thyrotropin receptor antibody%Urine microprotein%131 Iodine treatment
目的:探讨Graves病(简称GD)患者131 I治愈前后尿微量蛋白变化的影响因素。方法选择GD患者20例(GD组),根据131I治愈前后分成治疗前的GD组、治愈3个月R3M组、治愈12个月R12M组,并设正常对照组20例。采用全自动化学免疫发光法检测血清游离甲功3项[包括游离三碘甲状腺原氨酸( FT3)、游离甲状腺素( FT4)、促甲状腺素( TSH)]、促甲状腺受体抗体( TRAb)、尿微量白蛋白( Alb)、尿免疫球蛋白(IgG)、尿微球蛋白(β2-MG)含量。采用散射比浊法检测血清中超敏C反应蛋白(hs-CRP)。全自动血凝仪测定血清D-二聚体( D-D)。 SPECT计算总肾小球滤过率( TRGFR)。结果 GD组游离甲功3项与各组比较差异有统计学意义( P<0.01)。 GD组、R3M组的TRAb、Alb、IgG与其余组比较差异有统计学意义( P<0.01)。直线相关分析显示,FT3与Alb、IgG呈显著正相关( r分别为0.64、0.72, P均<0.01), TRAb与Alb、IgG呈显著正相关( r分别为0.66、0.56,P均<0.01)。结论 GD肾损害的部位在肾小球,与免疫紊乱关系密切;GD相关抗体的消失可作为判断GD肾损害的恢复及治疗效果的参考指标。
目的:探討Graves病(簡稱GD)患者131 I治愈前後尿微量蛋白變化的影響因素。方法選擇GD患者20例(GD組),根據131I治愈前後分成治療前的GD組、治愈3箇月R3M組、治愈12箇月R12M組,併設正常對照組20例。採用全自動化學免疫髮光法檢測血清遊離甲功3項[包括遊離三碘甲狀腺原氨痠( FT3)、遊離甲狀腺素( FT4)、促甲狀腺素( TSH)]、促甲狀腺受體抗體( TRAb)、尿微量白蛋白( Alb)、尿免疫毬蛋白(IgG)、尿微毬蛋白(β2-MG)含量。採用散射比濁法檢測血清中超敏C反應蛋白(hs-CRP)。全自動血凝儀測定血清D-二聚體( D-D)。 SPECT計算總腎小毬濾過率( TRGFR)。結果 GD組遊離甲功3項與各組比較差異有統計學意義( P<0.01)。 GD組、R3M組的TRAb、Alb、IgG與其餘組比較差異有統計學意義( P<0.01)。直線相關分析顯示,FT3與Alb、IgG呈顯著正相關( r分彆為0.64、0.72, P均<0.01), TRAb與Alb、IgG呈顯著正相關( r分彆為0.66、0.56,P均<0.01)。結論 GD腎損害的部位在腎小毬,與免疫紊亂關繫密切;GD相關抗體的消失可作為判斷GD腎損害的恢複及治療效果的參攷指標。
목적:탐토Graves병(간칭GD)환자131 I치유전후뇨미량단백변화적영향인소。방법선택GD환자20례(GD조),근거131I치유전후분성치료전적GD조、치유3개월R3M조、치유12개월R12M조,병설정상대조조20례。채용전자동화학면역발광법검측혈청유리갑공3항[포괄유리삼전갑상선원안산( FT3)、유리갑상선소( FT4)、촉갑상선소( TSH)]、촉갑상선수체항체( TRAb)、뇨미량백단백( Alb)、뇨면역구단백(IgG)、뇨미구단백(β2-MG)함량。채용산사비탁법검측혈청중초민C반응단백(hs-CRP)。전자동혈응의측정혈청D-이취체( D-D)。 SPECT계산총신소구려과솔( TRGFR)。결과 GD조유리갑공3항여각조비교차이유통계학의의( P<0.01)。 GD조、R3M조적TRAb、Alb、IgG여기여조비교차이유통계학의의( P<0.01)。직선상관분석현시,FT3여Alb、IgG정현저정상관( r분별위0.64、0.72, P균<0.01), TRAb여Alb、IgG정현저정상관( r분별위0.66、0.56,P균<0.01)。결론 GD신손해적부위재신소구,여면역문란관계밀절;GD상관항체적소실가작위판단GD신손해적회복급치료효과적삼고지표。
Objective To investigate the influence factors of the urine microprotein in the patients of Graves disease(GD) before and after cure with 131iodine(131I).Methods Twenty patients with GD were treated with 131I and 20 healthy person were used for normal control group (NG).The patients with GD were divided into GD group (before treatment with 131I), R3M group(3 months after of cure with 131I and R12M group(12 months after cure with 131 I) .The following biomakers were observeed in the above groups:3 free thyroid functions [ free three triiodothyro-nine(FT3), free thyroxine(FT4) and thyroid stimulating hormone(TSH)], thyrotropin receptor antibody(TRAb), urinary microalbumin(Alb), urine immunoglobulin(IgG) and urine β2-microglobulin(β2-MG) were measured by automatic chemical immune chemiluminescence .Serum high sensitivity C-reactive protein(hS-CRP) was detected by the scattering ratio.D-dimer was examined with Rate Nephelometry .And the total glomerular filtration rate ( TRGFR) was calculated by SPECT .Results There was a significant difference in 3 free thyroid functions in GD group com-pared with those in R3M group, R12M group and in NG(P<0.01).A significant difference of TRAb, urine Alb and IgG was observed in the GD group and R3M compared with those in R12M and in NG(P<0.01).Linear correlation analysis showed that there was significant positive correlation between FT 3 and Alb, IgG(r respectively were 0.64, 0.72 , P all <0.01 ) , TRAb was significantly positive correlated with Alb , IgG( r respectively were 0.66 , 0.56 , P all <0.01 ) .Conclusion The kidney damage of GD occurs in the glomerulus and it is closely related to immune dis -orders.The disappearance of the hyperthyroidism-related antibodies can be used as the effect reference index in the assessment of recovery and treatment of GD renal damage .